DRL share price

Global brokerage JPMorgan maintained an overweight rating on , Credit Suisse initiated underperform rating on and Goldman Sachs maintained a buy on . We have collated a list of…
Read More...

NEW DELHI: Dr Reddy's Laboratories () is likely to report a 25 per cent year-on-year (YoY) rise in net profit at Rs 710 crore, as per an ET NOW poll of analysts. The drugmaker had…
Read More...